Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
2021 Year in Review - Multiple Myeloma
2021 Year in Review: Advances in Dual IO Cancer Treatments
2021 Year in Review - Breast Cancer
2021 Oncology Drug Coding and Updates
2021 Year in Review - Renal-Cell Carcinoma
2021 Year in Review - Ovarian Cancer
2021 Year in Review - Gastrointestinal Cancer
2021 Year in Review - Non–Small-Cell Lung Cancer
2021 Year in Review - Biosimilars
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2021 Novel Oncology Drug Approvals
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
ASH 2021 - AML
ASH 2021 - Myelofibrosis
2021 Myelofibrosis Wrap-Up
AACR & ASCO 2021 - Midyear Review
ASCO 2021 - Lung Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2021
July 2021, Vol 11, No 7
July 2021, Vol 11, No 7
Best Practices for Optimizing Opioid Therapy in Patients with Cancer Pain
By
Charlie Dawson
HOPA Highlights
The COVID-19 pandemic may have temporarily overshadowed the opioid crisis in the United States, but deaths related to opioid overdose have risen to an all-time high in the past year. Although largely driven by synthetic opioids such as illicit fentanyl, frequently prescribed opioids have played a role in opioid overdose and opioid use disorder as well.
Read Article ›
Empowering Patients Through Advance Care Planning
By
Jan Hailey, MHL, CMC, CMCO, CMIS, CMOM
Practice Management
Advance care planning is the process of planning for future medical treatment in the event that patients are unable to make their own decisions. It ensures that patients receive healthcare services that are consistent with their personal wishes, culture, goals, and values.
Read Article ›
Tips on Biosimilars: A Financial Advocate Perspective
Biosimilars
As biosimilars are being used more and more in cancer treatment, it is increasingly important that navigators and financial advocates be familiar not only with how they work but also how patients with cancer should go about paying for them, according to Angie Santiago, AA, CRCS-I, lead financial advocate at the Sidney Kimmel Cancer Center/Jefferson Health.
Read Article ›
Updates on the Use of Anticoagulants for Cancer-Associated Thromboembolism
By
Charlie Dawson
HOPA Highlights
Thrombosis in patients with cancer may be a relatively common complication, but the treatment of venous thromboembolism (VTE) in this patient population is anything but simple. Patients with cancer have up to 6 times increased risk for recurrent VTE compared with patients without cancer, and they are also at higher risk for treatment-related side effects, such as bleeding. Furthermore, patients with cancer require longer-term use of anticoagulants, which raises concerns about quality of life and medication adherence.
Read Article ›
Immunotherapy Continues to Transform the Treatment Landscape for Advanced NSCLC
By
Charlie Dawson
HOPA Highlights
Lung cancer remains the leading cause of cancer death worldwide, but the treatment landscape is rapidly evolving. In the past 10 years alone, the number of drugs approved by the FDA for non–small-cell lung cancer (NSCLC) has exceeded the previous 10 decades combined.
Read Article ›
New Opportunities in Clinical Trials and Drug Development After COVID-19
By
Charlie Dawson
Clinical Trials
,
COVID-19
The process of clinical trials underwent a dramatic transformation amid the COVID-19 pandemic, according to Heidi D. Finnes, PharmD, BCOP, FHOPA, RPh, Senior Manager, Pharmacy Cancer Research, Mayo Clinic, Rochester, MN. Pharmacists must see this as an opportunity to evolve patient care in clinical trials long after the pandemic is over, Dr Finnes suggested at the 2021 Hematology/Oncology Pharmacy Association conference. Dr Finnes outlined efficiencies in pharmacy practice that should be enacted to accommodate changes in the way clinical trials are being conducted—such as remote patients and adverse events monitoring, mailing of the investigational drugs, and telehealth visits with study participants.
Read Article ›
Cryoablation Appears Safe and Effective for Low-Risk, Early-Stage Breast Cancer
By
William Ackerman
Breast Cancer
Breast cancer cryoablation, which destroys tumor cells by exposing them to subfreezing temperatures, appears to be an effective alternative to surgery for women aged >60 years with low-risk, early-stage breast cancer, according to interim results from the ICE3 trial. Interim results from this trial were presented by lead investigator Richard E. Fine, MD, FACS, Breast Surgeon, West Cancer Center & Research Institute, Germantown, TN, during the American Society of Breast Surgeons 22nd Annual Meeting.
Read Article ›
Medicaid Expansion Significantly Improves Breast Reconstruction Disparities
By
William Ackerman
Breast Cancer
Medicaid expansion under the Affordable Care Act was associated with significant increases in breast reconstruction surgery among non-Hispanic black women and women with lower income and education levels, according to results of a study presented during the American Society of Breast Surgeons 22nd Annual Meeting. At times, these increases achieved parity with non-Hispanic white women.
Read Article ›
Solving Infusion Scheduling Challenges for Better Patient Outcomes
Infusion Scheduling
Infusion centers face significant challenges related to lengthy wait times and uneven patient loads, which can negatively affect clinical outcomes and cause unnecessary burdens for nurses or other healthcare providers.
Oncology Practice Management (OPM)
recently spoke with Abbi Bruce, RN, MS, OCN, Program Director, Medical Oncology and Infusion Services, Hartford HealthCare Cancer Institute at Hartford Hospital, CT, who discussed some of the factors that contribute to the complexity of infusion scheduling, and effective strategies for solving these problems.
Read Article ›
Selpercatinib Demonstrates Activity in a Variety of RET Fusion–Positive Solid Tumor Types
By
Patricia Stewart
AACR Meeting Highlights
Selpercatinib (Retevmo) demonstrated antitumor activity in
RET
fusion–positive tumors other than lung cancer and thyroid cancer, according to interim results from the phase 1/2 LIBRETTO-001 clinical trial. Results from the trial were presented by Vivek Subbiah, MD, Medical Director, Clinical Center for Targeted Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, at the 2021 virtual American Association for Cancer Research annual meeting.
Read Article ›
Page 1 of 2
1
2
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
2022 Midyear Review: Non–Small-Cell Lung Cancer
2.
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers
By
Dawn Holcombe, MBA, FACMPE, ACHE
3.
Oncology Guide to Patient Support Services Index
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
2021 Year in Review - Multiple Myeloma
2021 Year in Review: Advances in Dual IO Cancer Treatments
2021 Year in Review - Breast Cancer
2021 Oncology Drug Coding and Updates
2021 Year in Review - Renal-Cell Carcinoma
2021 Year in Review - Ovarian Cancer
2021 Year in Review - Gastrointestinal Cancer
2021 Year in Review - Non–Small-Cell Lung Cancer
2021 Year in Review - Biosimilars
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2021 Novel Oncology Drug Approvals
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
ASH 2021 - AML
ASH 2021 - Myelofibrosis
2021 Myelofibrosis Wrap-Up
AACR & ASCO 2021 - Midyear Review
ASCO 2021 - Lung Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Subscribe Today!
To sign up for our newsletter or print publications, please enter your contact information below.
I'd like to receive:
OPM
Print Edition
OPM
Weekly e‑Newsletter
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, the Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, the former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
I have reviewed and consent to the terms of
OPM
's
Privacy Policy
, and
OPM
has my permission to retain my information in its database, and to forward pertinent communications to me.
START YOUR SUBSCRIPTION